The prognostic value of Ki67 immunostaining in non‐Hodgkin's lymphoma

The Journal of Pathology

Volumn 154, Issue 3, 1988, Pages 223-235

  Hall, P A ^a   Richards, M A ^a   Gregory, W M ^b   D'Ardenne, A J ^a   Lister, T A ^a   Stansfeld, A G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

cellular proliferation; Monoclonal antibody; non Hodgkin's lymphoma; prognosis; tumour cell kinetics

Indexed keywords

ANTIGEN;

CELL GROWTH; HISTOCHEMISTRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; SURVIVAL;

EID: 0023872827     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711540305     Document Type: Article

References (51)

1. Percentage of cells in the S phase of the cell cycle in human lymphoma determined by flow cytometry
2. Marker and kinetic studies in the non‐Hodgkin's lymphomas
3. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia
4. The biology of tumour growth in the non‐Hodgkin's lymphomas
5. Heterogeneity of non‐Hodgkin's lymphoma probed by nucleic acid cytometry
6. Correlation of kinetic findings with morphology of non‐Hodgkin's lymphomas
7. Labelling index as a prognostic marker in non‐Hodgkin's lymphoma
8. Uptake of thymidine in lymphoma cells obtained through fine‐needle aspiration biopsy. Relation to prognosis in non‐Hodgkin's lymphoma
9. 3H]‐thymidine uptake by histological subgroups of human B cell lymphomas
10. 3H] thymidine uptake in B cell lymphomas. Relationship to treatment response and survival
11. Correlation of transferrin receptor expression with histological class and outcome in non‐Hodgkin's lymphoma
12. Growth fraction of tumour cells and infiltration density with natural killer‐like cells in non‐Hodgkin's lymphomas
13. Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy
14. The pattern of cell growth in reticulum cell sarcoma and lymphosarcoma
15. A comparison of three methods for the determination of the growth fraction in non‐Hodgkin's lymphomas
16. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
17. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki67
18. Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki67
19. Immunohistologic demonstration of colonic crypt cell kinetics in ulcerative colitis
20. Growth fractions in breast carcinomas determined in situ with monoclonal antibody Ki67
21. Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables
22. New approach to assessing lung tumours in man
23. The use of the monoclonal antibody Ki67 in the identification of proliferating cells: application to surgical neuropathology
24. Ki67 labelling index in meningiomas. Histological correlates
25. Growth fractions in malignant non‐Hodgkin's lymphomas as determined in situ with the monoclonal antibody Ki67
26. Follicular lymphoma: prognostic factors for response and survival
27. Acetone–periodate lysine paraformaldehyde fixation and improved morphology for cryostat section immunostaining
28. Non‐parametric estimation from incomplete observations
29. Design analysis of randomised clinical trials requiring prolonged observations of each patient: II. Analysis and examples
30. Prognostic factors in lymphoma
31. Growth rate patterns of solid tumors and their relationships to responsiveness to therapy: an analytical review
32. Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy
33. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate
34. Cell proliferation kinetics of human malignant lymphoma
35. The biology of cell death in tumours
36. Cell loss factor in the growth of human tumours
37. The relationship between growth rate, labelling index and histological type of human solid tumours
38. Surface phenotyping, histology and the nature of non‐Hodgkin's lymphoma in 157 patients
39. Quantitation and estimation of lymphocyte subsets in tissue sections. Comparison with flow cytometry
40. Regional variations in proliferative rate and degree of differentiation in B16 melanomas
41. Proliferative rates of cloned malignant mammary epithelial cells as a measure of clonal heterogeneity in human breast carcinoma